Research Article
Role of ARPC2 in Human Gastric Cancer
Table 2
Correlation of ARPC2 expression with clinicopathological parameters from gastric cancer patients.
| Parameter | n | ARPC2 expression | Positive, n (%) | value |
| Age (years) | | ≤60 | 57 | 34 (59.6) | 0.367 | >60 | 53 | 36 (67.9) | | Gender | Male | 60 | 34 (56.7) | 0.096 | Female | 50 | 36 (72.0) | | Tumor size (cm) | | ≤5 | 73 | 38 (52.1) | 0.001 | >5 | 37 | 32 (86.5) | | Lymph node metastasis | | No | 34 | 15 (44.1) | 0.004 | Yes | 76 | 55 (72.4) | | Grade | | I | 11 | 8 (72.7) | 0.638 | II | 71 | 43 (60.6) | | III | 28 | 19 (67.9) | | Stage | | I-II | 57 | 25 (43.9) | 0.001 | III-IV | 53 | 45 (84.9) | |
|
|